Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:14 PM ET 10-Q
Financial Results Formfactor Inc FORM

Formfactor Q3 2026 Results: Net Income $73.8M, Up 371.5% YoY

FormFactor, Inc. reported significant growth for the third quarter of 2026, with revenues increasing to $280.5 million compared to $202.7 million in the prior year period. Net income rose substantially to $73.8 million, driven by higher gross profits and improved operating margins despite increased factory start-up costs.

Key figure
Net income $73.8M · +371.5% YoY
4:14 PM ET 10-Q
Financial Results UL Solutions Inc. ULS

UL Solutions Q3 2026 Results: Net Income $108M, Up 8.0% YoY

UL Solutions Inc. reported a significant increase in net income for the nine months ended September 30, 2026, reaching $469 million compared to $274 million in the prior year, largely driven by a $191 million gain on divestiture. Revenue grew 5.9% year-over-year to $2.4 billion, and the company reorganized its reporting segments into Industrial, Risk & Compliance Software, and Consumer segments.

Key figure
Net income $108M · +8.0% YoY
4:14 PM ET 8-K
M&A Deal Swarmer, Inc SWMR

Swarmer M&A Deal with Limited Liability Company Jk Land Vehicles

Swarmer, Inc. stockholders approved the issuance of up to 5,487,067 shares of common stock in connection with the acquisition of Ratel Robotics, a Ukrainian limited liability company. The issuance includes 1,064,942 shares at closing and up to 4,422,125 shares contingent upon the achievement of specific earnout targets. The approval satisfies Nasdaq requirements for the transaction originally announced in September 2026.

Counterparty
LIMITED LIABILITY COMPANY JK LAND VEHICLES (Ratel Robotics)
4:14 PM ET 10-Q
Financial Results Contineum Therapeutics, Inc. CTNM

Contineum Therapeutics Q3 2026 Results: Net Loss of $18.7M, Loss Widens

Contineum Therapeutics reported cash and cash equivalents of $75.2 million as of September 30, 2026, compared to $75.6 million at the end of 2025. The company remains in the early stages of clinical development, heavily dependent on its lead candidate PIPE-791 and its collaboration with J&J for PIPE-307.

Key figure
Net loss $18.7M
4:14 PM ET 10-Q
Financial Results Huron Consulting Group Inc. HURN

Huron Consulting Group Q3 2026 Results: Net Income $28.4M, Down 6.6% YoY

Huron Consulting Group reported a 12.8% increase in total revenues to $1.42 billion for the nine months ended September 30, 2026, compared to the prior year. Net income rose to $82.9 million from $74.4 million, driven by strong performance in operating income despite higher interest expenses and a significant increase in long-term debt to $793.9 million.

Key figure
Net income $28.4M · -6.6% YoY
4:14 PM ET Form 4
Insider Selling Piper Sandler Companies PIPR

Piper Sandler Companies President Debbra L. Schoneman Sells $2.68M of Stock

Debbra L. Schoneman, President, sold 39,708 shares of Piper Sandler Companies at $67.38 a share, worth $2.68M in total on Nov 2, 2026. Shares held after the trade: 11,752 (-77.2%).

Value
$2.68M
Shares
39,708
Price
$67.38
Role
President
Holding change
-77.2%
Trade date
Nov 2, 2026
4:13 PM ET 8-K
Financial Results American Well Corp AMWL

American Well Financial Results

American Well Corp (Amwell) reported Q3 2026 total revenue of $49.0 million, exceeding its previous guidance, and a net loss of $11.0 million. The company raised its full-year 2026 revenue outlook to a range of $204-$206 million and reiterated its goal to achieve positive cash flow from operations in the fourth quarter of 2026.

Term
Q3 2026

“Health plans and employers want engagement, outcomes and proof, and Amwell’s single platform is built to deliver all three. Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works. We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs.”

Dr. Ido Schoenberg, Chairman and CEO of Amwell
4:13 PM ET 8-K
Financial Results Toast, Inc. TOST

Toast Financial Results

Toast, Inc. reported third quarter 2026 financial results with revenue growth driven by a 24% increase in ARR to $2.5 billion and the addition of 8,500 net new locations. The company also announced that CFO Elena Gomez will step down at the end of 2026, to be succeeded by Michael Senno, the current SVP of Finance, effective January 1, 2027.

Term
Q3 2026

“We had another strong quarter: recurring gross profit streams grew 27%, GAAP Operating Income margin expanded to 26% and we added approximately 8,500 net locations.”

Aman Narang, Toast CEO

“Elena has been an exceptional partner to me and has played a critical role in shaping Toast’s success and financial strategy over the last five and a half years. We’ve scaled this business 6x since we IPO’d in 2021, dramatically improved profitability as the business has scaled, and built out the team and product lines to continue to drive durable growth over the long term.”

Aman Narang, Toast CEO
4:13 PM ET 8-K
Financial Results Block, Inc. XYZ

Block Financial Results

Block, Inc. reported strong third-quarter 2026 results with gross profit growing 22% year-over-year to $3.24 billion. The company saw significant growth in profitability, with Adjusted Operating Income rising 92% and Adjusted Diluted EPS increasing 109% compared to the prior year. Based on these results, Block raised its full-year 2026 guidance across gross profit, adjusted operating income, and adjusted EPS metrics.

Term
Q3 2026
4:13 PM ET 8-K
Financial Results Ufp Technologies Inc UFPT

Ufp Technologies Financial Results

UFP Technologies reported third quarter 2026 net income of $20.6 million on net sales of $172.4 million, representing 11.6% year-over-year growth. The results were driven by strong MedTech demand and organic sales growth of 11.1%, alongside scaling operations in the Dominican Republic.

Term
Q3 2026

“Our third quarter and year-to-date results reflect continued solid execution across the UFP platform and progress toward our long-term growth strategy. In the third quarter, sales grew 11.6%, including 11.1% organic growth, gross margins increased to 29.4%, and adjusted operating income grew 14.5%.”

Mitch Rock, President and Chief Executive Officer

“Looking ahead to 2027, we are optimistic about the strength and positioning of UFP. We have invested in additional capacity at DAS Medical to support double-digit growth and have continued to build and invest in the team.”

Mitch Rock, President and Chief Executive Officer
4:13 PM ET 8-K
Financial Results Fortune Brands Innovations, Inc. FBIN

Fortune Brands Innovations Financial Results

Fortune Brands Innovations reported Q3 2026 sales of $1.1 billion, a 3.1% decrease year-over-year, and GAAP EPS of $0.42. The company announced a multi-year turnaround plan including the sale of its Fiberon business, exiting commercial operations in China, and rationalizing its EMEA footprint to drive $70 million in annualized savings.

Term
Q3 2026

“Fortune Brands is in the early stages of a multi-year turnaround plan to get Back to Business. We are building from a strong foundation of brands that consumers and pros know and trust. Third quarter results were in line with our outlook excluding the tax and tariff benefits, but not where they need to be. Our biggest challenge has been our own execution, and we are taking aggressive steps to drive improvement.”

Jesse Singh, Chief Executive Officer

“I am confident that our actions will build a stronger, simpler and more customer-focused company that delivers consistent growth, margin expansion and shareholder value over the long term.”

Jesse Singh, Chief Executive Officer
4:13 PM ET 8-K
Financial Results Huron Consulting Group Inc. HURN

Huron Consulting Group Financial Results

Huron Consulting Group reported record Q3 2026 revenues of $482.5 million, an 11.6% increase year-over-year, driven by organic growth across all segments. The company raised its full-year 2026 adjusted diluted EPS guidance midpoint to $9.30 and increased its share repurchase authorization to $1.1 billion.

“We achieved record revenues before reimbursable expenses (RBR) in the third quarter of 2026, reflecting 12% growth over the third quarter of 2025. Our third quarter performance was driven by organic growth across all operating segments and double-digit percentage growth in our Consulting and Managed Services and Digital capabilities.”

Mark Hussey, chief executive officer and president
4:12 PM ET 8-K
Shareholder Meeting Kala BIO, Inc. KALA

Kala BIO Shareholder Meeting

KALA BIO held its Annual Meeting of Stockholders on November 3, 2026, where shareholders elected Yonatan Colman and Brendan Purdy as Class III directors. Stockholders also approved an advisory vote on executive compensation, ratified HTL International, LLC as the independent auditor, and authorized a potential reverse stock split at a ratio between 1-for-2 and 1-for-300.

4:12 PM ET 8-K
Business Update Safehold Inc. SAFE

Safehold Business Update

Safehold Inc. announced that the estimated unrealized capital appreciation (UCA) in its owned residual ground lease portfolio was $9.87 billion as of September 30, 2026. The UCA represents the aggregate value of the land and improvements associated with the company's ground leases in excess of their cost basis, reflecting potential value accretion upon property reversion.

4:12 PM ET Form 4
Insider Selling American Express Co AXP

American Express CLO Laureen Seeger Sells $22.9M of Stock

Laureen Seeger, CLO, sold 69,860 shares of American Express Co at $328.17 a share, worth $22.9M in total on Nov 2, 2026. Shares held after the trade: 9,002 (-88.6%).

Value
$22.9M
Shares
69,860
Price
$328.17
Role
CLO
Holding change
-88.6%
Trade date
Nov 2, 2026
4:12 PM ET 10-Q
Financial Results BlueLinx Holdings Inc. BXC ▶ Call

BlueLinx Holdings Q3 2026 Results: Net Loss of $625K

BlueLinx Holdings Inc. reported net sales of $812.6 million for the third quarter of 2026, an increase from $748.9 million in the prior year period, though it recorded a net loss of $0.6 million. For the nine months ended October 3, 2026, the company maintained profitability with a net income of $4.3 million, despite higher operating and interest expenses compared to 2025.

Key figure
Net loss $625K
4:12 PM ET 8-K
Financial Results SM Energy Co SM

SM Energy Financial Results

SM Energy reported third quarter 2026 financial results, generating $1.1 billion in operating cash flow and $397 million in adjusted free cash flow. The company returned $133 million to stockholders through dividends and share repurchases while redeeming $417 million in senior notes to strengthen its balance sheet following the Civitas merger integration.

Term
Q3 2026

“We are meaningfully transforming SM Energy – exceeding our merger synergy target, substantially achieving our divestiture target and materially strengthening the balance sheet. In the third quarter, we generated $1.1 billion of operating cash flow, redeemed $417 million of debt and returned $133 million to stockholders.”

Beth McDonald, President and CEO

“This is a multi-year journey, and our strong and resilient balance sheet is the foundation. We remain on track for low one-times leverage at mid-cycle prices by year-end 2026, strengthening the capacity for durable stockholder returns.”

Beth McDonald, President and CEO
4:12 PM ET Form 4
Insider Selling Icon PLC ICLR

Icon CFO Nigel Bernard John Clerkin Sells $303K of Stock

Nigel Bernard John Clerkin, CFO, sold 1,466 shares of Icon PLC at $204.91 to $208.00 a share (average $206.61) in 4 transactions, worth $303K in total on Nov 2, 2026. Shares held after the trade: 7,193 (-5.0%).

Value
$303K
Shares
1,466
Average price
$206.61
Role
CFO
Holding change
-5.0%
Trade date
Nov 2, 2026
4:12 PM ET 10-Q
Financial Results Corcept Therapeutics Inc CORT

Corcept Therapeutics Q3 2026 Results: Net Income $127M, Up 544.6% YoY

Corcept Therapeutics reported a significant increase in net income to $126.8 million for the third quarter of 2026, compared to $19.7 million in the prior year, driven by a 64% increase in product revenue. The company maintained a strong balance sheet with over $1 billion in total assets and continued its stock repurchase program, though it recorded a net loss in the first quarter of the year.

Key figure
Net income $127M · +544.6% YoY
4:12 PM ET 8-K
Financial Results Douglas Emmett Inc DEI

Douglas Emmett Financial Results

Douglas Emmett reported Q3 2026 financial results, highlighting positive office absorption for the fourth consecutive quarter and a significant increase in office occupancy to 76.7%. Despite a net loss of $9 million, the company noted that its Net Operating Income has recovered to 2019 levels, though performance remains pressured by higher interest expenses.

Term
Q3 2026
4:12 PM ET 10-Q
Financial Results Avery Dennison Corp AVY

Avery Dennison Q3 2026 Results: Net Income $170M, Up 2.0% YoY

Avery Dennison reported net sales of $2.33 billion for the third quarter of 2026, a 5.2% increase compared to the prior year. Net income for the nine months ended September 30, 2026, rose to $541.9 million, up from $521.6 million in 2025, driven by higher volume and productivity measures. The company identified significant risks including global economic conditions, raw material costs, and geopolitical uncertainty in the Middle East and Ukraine.

Key figure
Net income $170M · +2.0% YoY
4:12 PM ET 10-Q
Financial Results Expro Ltd XPRO

Expro Q3 2026 Results: Net Loss of $5.2M

For the nine months ended September 30, 2026, Expro Ltd reported total revenue of $1.20 billion, a slight decrease from $1.22 billion in the prior year period. The company swung to a net loss of $4.2 million compared to a net income of $45.9 million in 2025, primarily driven by higher operating costs and a significant increase in merger and integration expenses.

Key figure
Net loss $5.2M
4:11 PM ET 8-K
Financial Results Usana Health Sciences Inc USNA

Usana Health Sciences Financial Results

USANA Health Sciences reported third quarter 2026 net sales of $206 million and a net loss of $5.6 million. While Core Nutritional active customers declined year-over-year, the company saw an 18% sequential increase in Hiya active monthly subscribers and generated $36 million in year-to-date free cash flow.

Term
Q3 2026

“As we continue our transformation to an omnichannel health and wellness company, our third quarter results were mixed, with meaningful improvement in some areas and results that fell short of our expectations in others.”

Kevin Guest, Chairman and Chief Executive Officer

“In Core Nutritional, rebuilding our active customer base is our top priority and our single largest growth lever.”

Kevin Guest, Chairman and Chief Executive Officer
4:11 PM ET 10-Q
Financial Results Corebridge Financial, Inc. CRBG ▶ Call

Corebridge Financial Q3 2026 Results: Net Income $1.44B, Up 900.0% YoY

Corebridge Financial reported its third quarter 2026 results, highlighting a pending merger transaction with Equitable Holdings, Inc. The company maintains a large accelerated filer status with 438,475,911 shares of common stock outstanding as of October 30, 2026.

Key figure
Net income $1.44B · +900.0% YoY
4:11 PM ET 8-K
Financial Results Safehold Inc. SAFE

Safehold Financial Results

Safehold Inc. reported third quarter 2026 financial results, highlighted by revenue of $118.7 million and net income of $28.8 million. The company closed $38 million in new ground lease originations and noted that its estimated unrealized capital appreciation increased to $9.9 billion.

Term
Q3 2026

“We were pleased to convert additional multifamily ground leases in the third quarter at attractive yields and low GLTVs. While the recent rise in rates has added incremental volatility to transaction markets, we’re encouraged by the engagement we’re seeing with our customers, and are well-positioned with ample liquidity, no significant near-term maturities and an 18-year liability structure to capitalize on opportunities.”

Jay Sugarman, Chairman and Chief Executive Officer
4:11 PM ET 8-K
Financial Results Varonis Systems Inc VRNS

Varonis Systems Financial Results

Varonis Systems reported third quarter 2026 total revenues of $189.5 million, a 17% increase year-over-year, driven by significant growth in SaaS revenues which reached $185.1 million. The company noted it will not provide forward-looking guidance or hold an earnings call due to its pending acquisition by Proofpoint, a Thoma Bravo portfolio company.

Term
Q3 2026
4:11 PM ET 8-K
Investor Presentation National Bank Holdings Corp NBHC

National Bank Holdings Investor Presentation

National Bank Holdings Corp. (NBHC) has released an updated investor presentation for Q3 2026. The company intends to use this deck for upcoming meetings with investors, analysts, and other stakeholders to discuss its strategic objectives and financial trends.

4:11 PM ET 8-K
Financial Results Arista Networks, Inc. ANET

Arista Networks Financial Results

Arista Networks reported record Q3 2026 financial results with revenue of $3.66 billion, representing 58.5% year-over-year growth. The company achieved record profitability with non-GAAP diluted EPS of $1.20 and provided strong Q4 guidance reflecting continued momentum in AI networking infrastructure.

Term
Q3 2026

“Arista registered another momentous quarter with the highest year-over-year revenue growth since our IPO and record profitability, surpassing even my high expectations. This strong momentum across customer sectors highlights our increased relevance for the generative and agentic AI era.”

Jayshree Ullal, Chairperson and CEO of Arista Networks

“This quarter brought a true trifecta for our company, setting new record highs in revenue growth, net income, and EPS. I’m incredibly proud of the Arista team for their hard work in driving such outstanding performance for our shareholders.”

Chantelle Breithaupt, CFO
4:11 PM ET 8-K
Financial Results Neostellar Capital Corp. NSLR

Neostellar Capital Financial Results

Neostellar Capital Corp. reported its Q3 2026 financial results, showing a Net Asset Value (NAV) of $12.64 per share and total net assets of approximately $334.7 million. The company highlighted its formalized partnership with Magnetar and its investment portfolio of 34 companies, including significant positions in Whoop and OpenAI (via ARK Type One).

Term
Q3 2026

“During the third quarter, we formalized our partnership with Magnetar through Neostellar Advisors, expanding our resources for sourcing and due diligence and giving us greater flexibility to evaluate and structure investments.”

Mark Klein, Chairman and Chief Executive Officer

“We continue to see significant opportunity across the computing and data infrastructure supporting broader AI adoption, reflected in our investments in OpenAI, ClickHouse, TensorWave and CoreWeave.”

Mark Klein, Chairman and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.